report
random
doublemask
placebocontrol
clinic
studi
demonstr
effect
zinc
acet
lozeng
common
cold
symptom
allergytest
subject
subject
zinc
placebo
group
evenli
match
respect
sex
raceethu
allergi
test
statu
age
overal
symptom
durat
waz
significantli
less
zinc
group
placebo
group
mean
day
vs
day
mean
sever
rate
symptom
lower
zinc
group
placebo
group
differ
howev
statist
signific
allergyposit
subject
use
zinc
statist
signific
shorter
durat
nasal
symptom
allergyneg
subject
day
vs
day
conclus
propos
zinc
acet
lozeng
may
significantli
shorten
durat
common
cold
symptom
reliev
symptom
associ
allergi
common
cold
frequent
infect
age
group
unit
state
billion
spent
annual
cold
unit
state
yet
peopl
cold
spend
money
treat
estim
unit
state
billion
cold
occur
year
million
disabl
result
million
day
restrict
activ
million
lost
day
school
million
lost
day
work
although
well
recogn
cold
caus
rhinovirus
least
million
worth
antibiot
prescrib
common
cold
unit
acut
respiratori
disord
induc
type
virus
mainli
human
rhinovirus
cold
virus
infect
peopl
vari
time
year
includ
coronaviru
influenza
viru
herp
simplex
viru
respiratori
syncyti
viru
coxsackieviru
parainfluenza
viru
picornaviru
paramyxoviru
adenoviru
virus
usual
contagi
first
day
symptom
rhinovirus
caus
cold
symptom
yearround
implic
case
distinct
rhinovirus
exist
make
imposs
produc
use
vaccin
recent
literatur
offer
littl
support
use
antihistamin
treat
symptom
common
review
six
major
studi
vitamin
c
supplement
gave
evid
highdos
vitamin
c
supplement
decreas
incid
common
cold
report
zinc
ion
inhibit
rhinoviru
replicationg
sinc
observ
numer
studi
assess
efficaci
zinc
given
oral
lozeng
treatment
common
cold
symptom
effect
zinc
lozeng
durat
common
cold
symptom
inconsist
perhap
due
differ
formul
zinc
handbook
cure
common
cold
ebi
discuss
great
detail
understand
zinc
ion
work
propos
zinc
ion
interfer
rhinoviru
protein
cleavag
protect
plasma
membran
attach
surfac
rhinoviru
interfer
intercellular
adhes
molecul
wl
dock
point
rhinovirus
surfac
nasal
epitheli
cell
ebi
et
al
conduct
first
clinic
trial
use
zinc
glucon
lozeng
demonstr
zinc
shorten
durat
common
cold
symptom
second
clinic
trial
conduct
medic
research
council
common
cold
unit
salisburi
england
also
demonstr
shorter
durat
common
cold
symptom
zinc
lozeng
use
recent
random
doublemask
placebocontrol
zinc
lozeng
cleveland
clinic
demonstr
significantli
reduc
durat
symptom
common
cold
clinic
studi
howev
show
improv
cold
symptom
zinc
lozeng
use
recent
review
publish
clinic
studi
use
zinc
lozeng
coldslg
found
four
studi
report
zinc
salt
four
review
conclud
evid
still
lack
howev
also
state
four
studi
show
benefit
use
zinc
lozeng
substanc
known
complex
zinc
ion
wherea
four
studi
posit
result
use
ioniz
form
zinc
without
substanc
recent
evalu
effect
zinc
glucon
glycin
lozeng
cold
symptom
children
adolesc
result
show
advantag
use
zinc
lozeng
howev
author
admit
dose
zinc
may
low
cherri
flavor
may
inactiv
zinc
thu
ineffect
formul
may
bias
studi
present
studi
undertaken
test
effect
zinc
acet
lozeng
common
cold
symptom
result
past
clinic
investig
interpret
inconclus
formul
zinc
lozeng
ident
placebo
use
result
inadequ
mask
presenc
allergi
present
common
cold
symptom
address
subject
random
doublemask
placebocontrol
studi
volunt
recruit
campu
univers
texa
austin
post
announc
goal
volunt
plan
power
analysi
show
subject
per
group
need
detect
moder
effect
size
es
power
alpha
onetail
subject
year
age
mean
age
year
median
age
year
healthi
except
common
cold
symptom
subject
sign
inform
consent
form
approv
institut
review
board
patient
diari
complet
subject
subject
lost
followup
zinc
treatment
group
consist
subject
placebo
group
consist
subject
subject
given
bottl
lozeng
lozeng
zinc
contain
mg
zinc
dextros
base
subject
seriou
ill
organ
transplant
disabl
includ
human
immunodefici
viru
infect
exclud
studi
subject
instruct
use
antihistamin
decongest
aspirin
vitamin
supplement
none
subject
histori
alcohol
drug
abus
none
particip
investig
drug
studi
within
preced
day
physic
examin
within
accept
limit
women
neg
result
urin
pregnanc
test
common
cold
nasal
allergi
caus
mani
symptom
skin
test
perform
subject
determin
whether
allergi
present
subject
skin
test
differ
allergi
extract
use
duotiptest
applic
lincoln
diagnost
inc
decatur
illinoi
lower
forearm
allergi
extract
obtain
allergi
laboratori
ohio
columbu
ohio
extract
includ
ragwe
mix
burwe
marsh
elder
cedar
elm
bermuda
grass
johnson
grass
perenni
rye
grass
mountain
cedar
junip
virginia
live
oak
pecan
american
elm
alternaria
alternata
hormodenorum
cladosporioid
helminthosporium
sativum
cockroach
mix
american
german
cat
dander
dog
dander
dust
mite
mix
western
ragwe
neg
control
diluent
posit
control
histamin
wait
period
result
skin
test
measur
record
itch
swell
red
site
allergi
extract
applic
indic
posit
reaction
allergen
fortysix
subject
test
posit
allergi
neg
studi
conduct
juli
august
pollen
lowest
level
airborn
pollen
spore
count
high
mold
spore
scant
grass
studi
subject
posit
skin
test
result
allerg
mold
allerg
grass
practic
viewpoint
airborn
pollen
signific
factor
studi
elig
studi
subject
two
common
cold
symptom
nasal
drainag
nasal
congest
cough
fever
myalgia
headach
sore
throat
scratchi
throat
hoars
sneez
malais
will
use
lozeng
day
symptom
stop
random
doublemask
studi
subject
inform
individu
would
receiv
zinc
lozeng
would
receiv
placebo
subject
also
inform
requir
rate
record
symptom
diari
time
day
symptom
grade
follow
absent
mild
symptom
present
particularli
discomfort
moder
symptom
clearli
evid
discomfort
sever
symptom
seriou
problem
clearli
evid
discomfort
subject
instruct
use
lozeng
everi
hour
awak
day
one
lozeng
everi
hour
awak
follow
day
symptom
present
stop
take
lozeng
hour
symptom
stop
subject
record
symptom
everi
day
symptom
ceas
consid
day
involv
studi
end
subject
interview
regard
accuraci
diari
entri
last
visit
compens
particip
studi
chisquar
test
use
determin
whether
subject
zinc
placebo
group
evenli
distribut
respect
sex
race
ethnic
allergi
test
statu
independ
group
test
use
test
differ
zinc
placebo
group
mean
age
mean
number
day
symptom
mean
symptom
sever
rate
although
distribut
outcom
variabl
depart
slightli
moder
normal
parametr
test
use
even
sever
departur
normal
make
littl
practic
differ
conclus
reach
long
sampl
size
least
moder
control
subject
allergi
test
statu
twoway
analysi
varianc
anova
procedur
use
determin
whether
mean
number
day
symptom
mean
symptom
sever
rate
differ
respect
treatment
group
allergi
test
statu
consid
simultan
data
analys
conduct
use
spss
version
valu
given
result
mean
f
standard
error
mean
em
tabl
show
distribut
subject
treatment
group
sex
raceethn
allergi
test
statu
studi
group
predominantli
white
rel
even
distribut
sex
allergi
test
statu
chisquar
test
show
signific
associ
treatment
group
membership
sex
raceethn
allergi
test
statu
independ
group
test
show
signific
differ
mean
age
zinc
group
f
year
placebo
group
f
year
df
p
subject
lost
followup
none
remain
subject
discontinu
side
effect
lozeng
mean
total
lozeng
taken
subject
studi
averag
lozeng
per
subject
per
day
long
symptom
persist
achiev
mask
sucros
octaacet
mg
use
placebo
placebo
zinc
lozeng
peppermint
flavor
review
subject
diari
entri
reveal
subject
note
chalki
tast
experienc
metal
aftertast
complain
upset
stomach
none
subject
note
bitter
tast
subject
like
peppermint
flavor
tabl
ii
show
mean
durat
symptom
durat
symptom
number
symptom
mean
durat
longestlast
symptom
symptom
longest
durat
mean
sever
rate
mean
score
symptom
treatment
group
independ
group
test
show
mean
durat
symptom
significantli
lower
zinc
group
day
placebo
group
day
p
figur
mean
durat
longestlast
symptom
also
significantli
lower
zinc
group
day
placebo
group
day
p
figur
th
e
mean
sever
rate
symptom
lower
zinc
group
sem
placebo
group
howev
differ
statist
signific
symptom
present
gener
rate
mild
moder
tabl
iii
show
mean
durat
symptom
treatment
group
independ
group
test
show
mean
durat
nasal
drainag
symptom
significantli
lower
zinc
group
day
placebo
group
f
day
df
p
test
also
show
mean
durat
nasal
congest
symptom
significantli
lower
zinc
group
f
day
placebo
group
f
day
df
p
none
mean
durat
symptom
consid
individu
significantli
differ
treatment
group
tabl
iii
also
show
mean
sever
rate
symptom
treatment
group
mean
symptom
sever
rate
lower
zinc
group
placebo
group
symptom
howev
none
differ
statist
signific
mean
symptom
rate
rang
mild
moder
anova
procedur
use
determin
whether
number
day
symptom
symptom
sever
rate
differ
respect
treatment
group
allergi
test
statu
consid
simultan
mean
durat
nasal
drainag
symptom
treatment
group
al
lergi
test
statu
shown
tabl
iv
anova
show
mean
durat
nasal
drainag
symptom
significantli
lower
zinc
group
day
n
placebo
group
day
n
f
df
p
howev
anova
also
show
signific
interact
effect
treatment
group
allergi
statu
group
f
df
p
differ
even
pronounc
allergyposit
subject
f
day
zinc
group
vs
f
day
placebo
group
allergyneg
subject
day
zinc
group
vs
day
placebo
group
find
suggest
person
posit
allergi
respons
zinc
allergyneg
person
relief
nasal
drainag
symptom
anova
show
signific
differ
symptom
regardless
number
day
symptom
exist
enter
studi
treatment
group
allergi
statu
group
discuss
result
random
doublemask
placebocontrol
studi
suggest
use
zinc
acet
lozeng
significantli
reduc
durat
common
cold
symptom
studi
although
descript
also
demonstr
symptom
resolv
significantli
quickli
zinc
group
placebo
group
mean
sever
rate
lower
zinc
group
placebo
group
furthermor
mean
durat
nasal
drainag
symptom
zinc
group
shorter
allergyposit
subject
allergyneg
subject
explain
differ
result
previou
clinic
trial
due
variat
zinc
ion
avail
note
posit
charg
zinc
ion
shorten
durat
common
cold
symptom
studi
use
zinc
lozeng
releas
posit
charg
zinc
ion
physiolog
ph
demonstr
impress
benefici
result
lozeng
use
studi
contain
mg
zinc
tablet
base
agglomer
dextros
watersolubl
ingredi
dissolv
mouth
minut
hatch
berthon
found
zinc
acet
releas
essenti
zinc
ion
physiolog
ph
lower
zinc
essenti
trace
element
human
biolog
necessari
mani
biolog
function
growth
appetit
testicular
matur
shin
integr
mental
activ
wound
heal
immun
system
mainten
approxim
enzym
known
requir
zinc
activ
zinc
defici
human
widespread
preval
area
popul
subsist
cereal
protein
clinic
manifest
zinc
defici
includ
growth
retard
hypogonad
male
neurosensori
disord
cellmedi
immunolog
dysfunct
increas
matern
morbid
prematur
deliveri
zinc
defici
also
advers
affect
prolifer
regul
matur
ejpetruset
relationship
zinc
common
cold
well
review
cold
caus
rhinovirus
korant
et
determin
zinc
ion
inhibit
rhinovir
replic
cleavag
rhinoviru
polypeptid
khinovirus
found
bind
receptor
found
nasal
epithelium
zinc
ion
complex
icamlbind
site
prevent
rhinoviru
attach
nasal
tissu
point
briefli
mention
korant
et
zincblock
virus
infect
nasal
tissu
cell
replic
infecti
process
would
interrupt
durat
cold
would
markedli
shorten
zinc
also
believ
act
proteas
inhibitor
effect
rhinoviru
infect
common
coldcaus
virus
inhibit
zinc
ion
includ
herp
simplex
zinc
ion
benefit
may
shorten
sever
durat
nonvir
symptom
associ
common
cold
zinc
antibacteri
activ
inhibit
growth
streptococci
actinomyc
use
dentifric
zinc
compound
antisept
antifung
astring
astring
zinc
use
zinc
acet
lozeng
common
cow
symptom
therapeut
arrest
hemorrhag
coagul
blood
check
diarrhea
reduc
inflamm
mucou
membran
promot
heal
toughen
skin
decreas
sweat
zinc
domin
biolog
action
membran
stabil
zinc
essenti
element
immun
system
function
regard
effect
zinc
allergi
mast
cell
implic
mediat
type
allerg
reaction
common
cold
symptom
caus
tissu
red
inflamm
nasal
congest
releas
mucu
goblet
cell
nose
throat
pain
tickl
itchi
indirectli
cough
sneez
mast
cellderiv
reaction
result
histamin
heparin
prostaglandin
slowreact
substanc
anaphylaxi
variou
vasoact
amin
releas
granul
surfac
mast
cell
possibl
includ
kinin
one
product
mast
cellinduc
inflamm
respons
rhinovir
infect
feverl
inhibitori
effect
zinc
histamin
releas
mast
cell
attribut
action
stabil
mast
cell
zinc
ion
found
stabil
cell
plasma
membran
prevent
induc
histamin
vasoact
amin
releas
tissu
mast
observ
unsequest
zinc
ion
mm
releas
mast
cell
granul
inflamm
suggest
common
linkag
allergi
common
cold
maron
et
believ
zinc
competit
antagonist
histamin
releas
human
basophil
suggest
zinc
compound
might
consid
treatment
allerg
propos
cell
membran
stabil
like
mechan
action
treatment
common
cold
lozeng
releas
posit
charg
zinc
ion
purpos
studi
subject
evalu
effect
zinc
acet
lozeng
durat
sever
common
cold
symptom
verifi
antivir
effect
zinc
previous
publish
studi
found
zinc
acet
lozeng
significantli
reduc
durat
common
cold
symptom
zinc
acet
lozeng
effect
reduc
durat
nasal
drainag
symptom
allergyposit
subject
hypothes
zinc
lozeng
may
use
first
line
treatment
allergi
symptom
recommend
addit
research
use
zinc
allergi
therapi
